questionsmedicales.fr
États, signes et symptômes pathologiques
Processus pathologiques
Processus néoplasiques
Processus néoplasiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Complement Inactivating Agents
Diagnostic
5
Diagnostic du cancer
Biopsie
Dépistage du cancer
Mammographie
Biopsie
Analyse histologique
Marqueurs tumoraux
Cancer
Stadification du cancer
Imagerie médicale
Symptômes
5
Symptômes du cancer
Fatigue
Types de cancer
Symptômes
Prévention
5
Prévention du cancer
Mode de vie sain
Alimentation
Antioxydants
Exercice physique
Risque de cancer
Traitements
5
Chimiothérapie
Radiothérapie
Immunothérapie
Système immunitaire
Radiothérapie
Rayonnements
Chimiothérapie
Effets secondaires
Complications
5
Complications du cancer
Métastases
Métastases
Traitement du cancer
Douleur cancéreuse
Gestion de la douleur
Chimiothérapie
Complications
Effets secondaires
Soins de soutien
Facteurs de risque
5
Facteurs de risque
Tabagisme
Hérédité
Antécédents familiaux
Produits chimiques
Risque de cancer
Alimentation
Risque de cancer
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Processus néoplasiques : Questions médicales les plus fréquentes",
"headline": "Processus néoplasiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Processus néoplasiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-18",
"dateModified": "2025-04-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Processus néoplasiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Processus pathologiques",
"url": "https://questionsmedicales.fr/mesh/D010335",
"about": {
"@type": "MedicalCondition",
"name": "Processus pathologiques",
"code": {
"@type": "MedicalCode",
"code": "D010335",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Anaplasie",
"alternateName": "Anaplasia",
"url": "https://questionsmedicales.fr/mesh/D000708",
"about": {
"@type": "MedicalCondition",
"name": "Anaplasie",
"code": {
"@type": "MedicalCode",
"code": "D000708",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.045"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Carcinogenèse",
"alternateName": "Carcinogenesis",
"url": "https://questionsmedicales.fr/mesh/D063646",
"about": {
"@type": "MedicalCondition",
"name": "Carcinogenèse",
"code": {
"@type": "MedicalCode",
"code": "D063646",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Transformation cellulaire néoplasique",
"alternateName": "Cell Transformation, Neoplastic",
"url": "https://questionsmedicales.fr/mesh/D002471",
"about": {
"@type": "MedicalCondition",
"name": "Transformation cellulaire néoplasique",
"code": {
"@type": "MedicalCode",
"code": "D002471",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Crise blastique",
"alternateName": "Blast Crisis",
"url": "https://questionsmedicales.fr/mesh/D001752",
"about": {
"@type": "MedicalCondition",
"name": "Crise blastique",
"code": {
"@type": "MedicalCode",
"code": "D001752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500.110"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Crise blastique",
"alternateName": "Blast Crisis",
"url": "https://questionsmedicales.fr/mesh/D001752",
"about": {
"@type": "MedicalCondition",
"name": "Crise blastique",
"code": {
"@type": "MedicalCode",
"code": "D001752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.500.110"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cocancérogenèse",
"alternateName": "Cocarcinogenesis",
"url": "https://questionsmedicales.fr/mesh/D003043",
"about": {
"@type": "MedicalCondition",
"name": "Cocancérogenèse",
"code": {
"@type": "MedicalCode",
"code": "D003043",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.098.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Invasion tumorale",
"alternateName": "Neoplasm Invasiveness",
"url": "https://questionsmedicales.fr/mesh/D009361",
"about": {
"@type": "MedicalCondition",
"name": "Invasion tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009361",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.645"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Infiltration leucémique",
"alternateName": "Leukemic Infiltration",
"url": "https://questionsmedicales.fr/mesh/D017254",
"about": {
"@type": "MedicalCondition",
"name": "Infiltration leucémique",
"code": {
"@type": "MedicalCode",
"code": "D017254",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.645.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Métastase tumorale",
"alternateName": "Neoplasm Metastasis",
"url": "https://questionsmedicales.fr/mesh/D009362",
"about": {
"@type": "MedicalCondition",
"name": "Métastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D009362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Extension extranodale",
"alternateName": "Extranodal Extension",
"url": "https://questionsmedicales.fr/mesh/D000079822",
"about": {
"@type": "MedicalCondition",
"name": "Extension extranodale",
"code": {
"@type": "MedicalCode",
"code": "D000079822",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métastase lymphatique",
"alternateName": "Lymphatic Metastasis",
"url": "https://questionsmedicales.fr/mesh/D008207",
"about": {
"@type": "MedicalCondition",
"name": "Métastase lymphatique",
"code": {
"@type": "MedicalCode",
"code": "D008207",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.560"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Micrométastase tumorale",
"alternateName": "Neoplasm Micrometastasis",
"url": "https://questionsmedicales.fr/mesh/D061206",
"about": {
"@type": "MedicalCondition",
"name": "Micrométastase tumorale",
"code": {
"@type": "MedicalCode",
"code": "D061206",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.695"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Essaimage tumoral",
"alternateName": "Neoplasm Seeding",
"url": "https://questionsmedicales.fr/mesh/D009366",
"about": {
"@type": "MedicalCondition",
"name": "Essaimage tumoral",
"code": {
"@type": "MedicalCode",
"code": "D009366",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.830"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Métastases d'origine inconnue",
"alternateName": "Neoplasms, Unknown Primary",
"url": "https://questionsmedicales.fr/mesh/D009382",
"about": {
"@type": "MedicalCondition",
"name": "Métastases d'origine inconnue",
"code": {
"@type": "MedicalCode",
"code": "D009382",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.895"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Cellules tumorales circulantes",
"alternateName": "Neoplastic Cells, Circulating",
"url": "https://questionsmedicales.fr/mesh/D009360",
"about": {
"@type": "MedicalCondition",
"name": "Cellules tumorales circulantes",
"code": {
"@type": "MedicalCode",
"code": "D009360",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.650.900"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Récidive tumorale locale",
"alternateName": "Neoplasm Recurrence, Local",
"url": "https://questionsmedicales.fr/mesh/D009364",
"about": {
"@type": "MedicalCondition",
"name": "Récidive tumorale locale",
"code": {
"@type": "MedicalCode",
"code": "D009364",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.655"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Maladie résiduelle",
"alternateName": "Neoplasm, Residual",
"url": "https://questionsmedicales.fr/mesh/D018365",
"about": {
"@type": "MedicalCondition",
"name": "Maladie résiduelle",
"code": {
"@type": "MedicalCode",
"code": "D018365",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dépendance oncogène",
"alternateName": "Oncogene Addiction",
"url": "https://questionsmedicales.fr/mesh/D000074723",
"about": {
"@type": "MedicalCondition",
"name": "Dépendance oncogène",
"code": {
"@type": "MedicalCode",
"code": "D000074723",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.727.850"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Processus néoplasiques",
"alternateName": "Neoplastic Processes",
"code": {
"@type": "MedicalCode",
"code": "D009385",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Barbara A Centeno",
"url": "https://questionsmedicales.fr/author/Barbara%20A%20Centeno",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA, Barbara.Centeno@moffitt.org."
}
},
{
"@type": "Person",
"name": "Sarah C Thomas",
"url": "https://questionsmedicales.fr/author/Sarah%20C%20Thomas",
"affiliation": {
"@type": "Organization",
"name": "Office of Chief Medical Examiner, New York, New York, USA."
}
},
{
"@type": "Person",
"name": "Guoqiang Zeng",
"url": "https://questionsmedicales.fr/author/Guoqiang%20Zeng",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China."
}
},
{
"@type": "Person",
"name": "Honglan Zhou",
"url": "https://questionsmedicales.fr/author/Honglan%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China."
}
},
{
"@type": "Person",
"name": "Yuantao Wang",
"url": "https://questionsmedicales.fr/author/Yuantao%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. Electronic address: wangyuantaobs@jlu.edu.cn."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "What complements complement in transplant-associated thrombotic microangiopathy?",
"datePublished": "2022-08-09",
"url": "https://questionsmedicales.fr/article/35942659",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bjh.18402"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complement Inhibitors in the Management of Complement-Mediated Hemolytic Uremic Syndrome and Paroxysmal Nocturnal Hemoglobinuria.",
"datePublished": "2023-05-01",
"url": "https://questionsmedicales.fr/article/37104648",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MJT.0000000000001609"
}
},
{
"@type": "ScholarlyArticle",
"name": "Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors.",
"datePublished": "2024-08-31",
"url": "https://questionsmedicales.fr/article/39273426",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms25179477"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of complement in humoral immunity.",
"datePublished": "2023-08-13",
"url": "https://questionsmedicales.fr/article/37582054",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MOT.0000000000001095"
}
},
{
"@type": "ScholarlyArticle",
"name": "With complements: C3 inhibition in the clinic.",
"datePublished": "2022-09-25",
"url": "https://questionsmedicales.fr/article/36161656",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/imr.13138"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Processus néoplasiques",
"item": "https://questionsmedicales.fr/mesh/D009385"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Processus néoplasiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Processus néoplasiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Processus néoplasiques",
"description": "Comment diagnostiquer un cancer ?\nQuels tests sont utilisés pour le dépistage ?\nQu'est-ce qu'une biopsie ?\nQuels sont les marqueurs tumoraux ?\nComment évaluer le stade d'un cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Inactivating+Agents#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Processus néoplasiques",
"description": "Quels sont les symptômes courants du cancer ?\nComment reconnaître une tumeur ?\nQuels signes indiquent un cancer avancé ?\nLes symptômes varient-ils selon le type de cancer ?\nQu'est-ce que la cachexie ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Inactivating+Agents#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Processus néoplasiques",
"description": "Comment prévenir le cancer ?\nLe vaccin contre le HPV prévient-il le cancer ?\nQuels aliments aident à prévenir le cancer ?\nL'exercice physique réduit-il le risque de cancer ?\nLe dépistage précoce est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Inactivating+Agents#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Processus néoplasiques",
"description": "Quels sont les traitements standards du cancer ?\nQu'est-ce que l'immunothérapie ?\nComment fonctionne la radiothérapie ?\nQuels sont les effets secondaires de la chimiothérapie ?\nQuand est-ce que la chirurgie est nécessaire ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Inactivating+Agents#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Processus néoplasiques",
"description": "Quelles sont les complications du cancer ?\nComment les métastases affectent-elles le traitement ?\nQu'est-ce que la douleur cancéreuse ?\nLes traitements peuvent-ils causer des complications ?\nComment gérer les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Inactivating+Agents#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Processus néoplasiques",
"description": "Quels sont les principaux facteurs de risque du cancer ?\nL'hérédité joue-t-elle un rôle dans le cancer ?\nLe stress est-il un facteur de risque ?\nL'exposition à des produits chimiques augmente-t-elle le risque ?\nL'alimentation influence-t-elle le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D009385?mesh_terms=Complement+Inactivating+Agents#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un cancer ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des examens cliniques, imageries et biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le dépistage ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent mammographies, coloscopies et tests sanguins spécifiques."
}
},
{
"@type": "Question",
"name": "Qu'est-ce qu'une biopsie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie consiste à prélever un échantillon de tissu pour analyse histologique."
}
},
{
"@type": "Question",
"name": "Quels sont les marqueurs tumoraux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs tumoraux sont des substances produites par les cellules cancéreuses, détectables dans le sang."
}
},
{
"@type": "Question",
"name": "Comment évaluer le stade d'un cancer ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stade est évalué par des examens d'imagerie et des classifications comme TNM."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du cancer ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, perte de poids, douleurs et changements cutanés."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une tumeur ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une tumeur peut se manifester par une masse palpable, des douleurs ou des changements fonctionnels."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un cancer avancé ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des douleurs persistantes, des saignements inexpliqués et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de cancer ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de cancer présente des symptômes spécifiques selon l'organe touché."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la cachexie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "La cachexie est une perte de poids et de masse musculaire souvent associée au cancer."
}
},
{
"@type": "Question",
"name": "Comment prévenir le cancer ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, l'évitement du tabac et des dépistages réguliers."
}
},
{
"@type": "Question",
"name": "Le vaccin contre le HPV prévient-il le cancer ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vaccin contre le HPV réduit le risque de cancers liés au virus, comme le cancer du col."
}
},
{
"@type": "Question",
"name": "Quels aliments aident à prévenir le cancer ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les fruits, légumes, grains entiers et aliments riches en antioxydants sont bénéfiques."
}
},
{
"@type": "Question",
"name": "L'exercice physique réduit-il le risque de cancer ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier est associé à un risque réduit de plusieurs types de cancer."
}
},
{
"@type": "Question",
"name": "Le dépistage précoce est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce permet de détecter le cancer à un stade plus traitable."
}
},
{
"@type": "Question",
"name": "Quels sont les traitements standards du cancer ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent chirurgie, chimiothérapie, radiothérapie et immunothérapie."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'immunothérapie ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'immunothérapie utilise le système immunitaire pour combattre les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Comment fonctionne la radiothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie utilise des rayonnements pour détruire les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la chimiothérapie ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent nausées, fatigue, perte de cheveux et infections."
}
},
{
"@type": "Question",
"name": "Quand est-ce que la chirurgie est nécessaire ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent nécessaire pour retirer des tumeurs localisées ou pour un diagnostic."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du cancer ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent métastases, infections, et effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Comment les métastases affectent-elles le traitement ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les métastases compliquent le traitement et peuvent nécessiter des approches plus agressives."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que la douleur cancéreuse ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La douleur cancéreuse est causée par la tumeur ou les traitements, nécessitant une gestion adéquate."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils causer des complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements comme la chimiothérapie peuvent entraîner des complications comme des infections."
}
},
{
"@type": "Question",
"name": "Comment gérer les effets secondaires des traitements ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des médicaments, des soins de soutien et des conseils nutritionnels."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque du cancer ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le tabagisme, l'alcool, l'obésité et l'exposition à des agents carcinogènes."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle dans le cancer ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque de certains types de cancer."
}
},
{
"@type": "Question",
"name": "Le stress est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut influencer le risque de cancer, bien que les preuves soient variées."
}
},
{
"@type": "Question",
"name": "L'exposition à des produits chimiques augmente-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques comme l'amiante ou le benzène est un facteur de risque."
}
},
{
"@type": "Question",
"name": "L'alimentation influence-t-elle le risque de cancer ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en graisses et pauvre en fibres peut augmenter le risque de cancer."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/04/2025
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA, Barbara.Centeno@moffitt.org.
Department of Oncologic Sciences, Morsani College of Medicine, University of South Florida, Tampa, Florida, USA, Barbara.Centeno@moffitt.org.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Office of Chief Medical Examiner, New York, New York, USA.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Urological Department, First Hospital of Jilin University, Changchun 130021, Jilin Province, China. Electronic address: wangyuantaobs@jlu.edu.cn.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Laborato´ rio de Embriologia Molecular e Caˆncer, Federal University of Santa Catarina, Floriano´ polis, SC 88040-900, Brazil.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Suhut State Hospital, 03800, Afyon, Turkey.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Hacettepe University School of Medicine, Sihhiye, 06230, Ankara, Turkey.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany. j.nawabi@uke.de.
Publications dans "Processus néoplasiques" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic and Interventional Neuroradiology, University Medical Center Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Anaesthesiology and Intensive Care, Pomeranian Medical University in Szczecin, Unii Lubelskiej 1 St., 71-281 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wlkp. 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Medical Chemistry, Pomeranian Medical University in Szczecin, Powstańców Wielkopolskich 72 Av., 70-111 Szczecin, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Analytical Chemistry, Medical University of Bialystok, Mickiewicza 2D, 15-222 Bialystok, Poland.
Publications dans "Processus néoplasiques" :
1 publication dans cette catégorie
Affiliations :
Department of Pathology, Banner-University Medical Center, College of Medicine, University of Arizona, Tucson AZ, USA.
Publications dans "Processus néoplasiques" :
Transplant-associated thrombotic microangiopathy remains a lethal complication of haematopoietic stem cell transplant and not all patients respond to terminal complement inhibitors. Qi et al. show tha...
Complement-mediated HUS (CM-HUS) and paroxysmal nocturnal hemoglobinuria (PNH) are rare hematologic disorders that cause dysregulation and hyperactivation of the complement system. Historically, treat...
Eculizumab, the first humanized anti-C5 monoclonal antibody, has been the standard of care in treating CM-HUS and PNH for over a decade. Although eculizumab has remained an effective agent, the variab...
Recently, there has been a push to formulate complement inhibitors that improve QOL while maintaining efficacy. Ravulizumab, a derivative of eculizumab, was developed to allow for less frequent admini...
Complement inhibitor therapies have changed the treatment landscape for CM-HUS and PNH. With a significant emphasis on patient QOL, novel therapies continue to emerge and require an in-depth review of...
A 47-year-old woman with hypertension and hyperlipidemia presented with shortness of breath and was found to have hypertensive emergency in the setting of acute renal failure. Her serum creatinine was...
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and potentially life-threatening hematologic disorder caused by a somatic mutation in a relevant portion of hematopoietic stem cells. Mutation of th...
Antibody-mediated rejection (AMR) after solid organ transplantation remains an unsolved problem and leads to poor early and late patient outcomes. The complement system is a well recognized pathogenic...
Activation and regulation of the complement cascade is critical not only for the terminal effector function of donor-specific antibodies, but also for the regulation of T and B cell subsets to generat...
The complement cascade is a critical mediator of AMR and clinical trials have shown early promising results. With the steady emergence of novel complement inhibitors and our greater understanding of t...
C3 is a key complement protein, located at the nexus of all complement activation pathways. Extracellular, tissue, cell-derived, and intracellular C3 plays critical roles in the immune response that i...
Innate immunity, and more specifically the complement system, has arised renewed interest in the medical field in recent years. Many innovative complement-inhibiting drugs have appeared, acting at var...
Complement is a central part of the immune system. In the human body, complement is responsible for recognition of infectious microbes, for coordinating the adaptive immune response, controlling homeo...
Age-related macular degeneration (AMD) is a common eye disease and leading cause of sight loss worldwide. Despite its high prevalence and increasing incidence as populations age, AMD remains incurable...
To assess the effects and safety of complement inhibitors in the prevention or treatment of AMD....
We searched CENTRAL on the Cochrane Library, MEDLINE, Embase, LILACS, Web of Science, ISRCTN registry, ClinicalTrials.gov, and the WHO ICTRP to 29 June 2022 with no language restrictions. We also cont...
We included randomised controlled trials (RCTs) with parallel groups and comparator arms that studied complement inhibition for advanced AMD prevention/treatment....
Two authors independently assessed search results and resolved discrepancies through discussion. Outcome measures evaluated at one year included change in best-corrected visual acuity (BCVA), untransf...
Ten RCTs with 4052 participants and eyes with GA were included. Nine evaluated intravitreal (IVT) administrations against sham, and one investigated an intravenous agent against placebo. Seven studies...
Despite confirmation of the negative findings of intravitreal lampalizumab across all endpoints, local complement inhibition with intravitreal pegcetacoplan meaningfully reduces GA lesion growth relat...
Hereditary complement deficiencies are relatively rare worldwide, they account for about 1-10% of primary immunodeficiencies. Acquired complement deficiencies are more prevalent and with the more freq...
Historically, the complement system (classical, lectin, alternative, and terminal pathways) is known to play a crucial role in the etiopathogenesis of many kidney diseases. Direct or indirect activati...